Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

UK National Screening Committee's approach to reviewing evidence on artificial intelligence in breast cancer screening

Tools
- Tools
+ Tools

Taylor-Phillips, Sian, Seedat, Farah, Kijauskaite, Goda, Marshall, John, Halligan, Steve, Hyde, Chris, Given-Wilson, Rosalind, Wilkinson, Louise, Denniston, Alastair K., Glocker, Ben, Garrett, Peter, Mackie, Anne and Steele, Robert J. (2022) UK National Screening Committee's approach to reviewing evidence on artificial intelligence in breast cancer screening. The Lancet. Digital health, 4 (7). e558-e565. doi:10.1016/S2589-7500(22)00088-7 ISSN 2589-7500. [ 🗎 Public].

[img]
Preview
PDF
PIIS2589750022000887.pdf - Published Version - Requires a PDF viewer.
Available under License Creative Commons Attribution 4.0.

Download (472Kb) | Preview
Official URL: https://doi.org/10.1016/S2589-7500(22)00088-7

Request Changes to record.

Abstract

Artificial intelligence (AI) could have the potential to accurately classify mammograms according to the presence or absence of radiological signs of breast cancer, replacing or supplementing human readers (radiologists). The UK National Screening Committee's assessments of the use of AI systems to examine screening mammograms continues to focus on maximising benefits and minimising harms to women screened, when deciding whether to recommend the implementation of AI into the Breast Screening Programme in the UK. Maintaining or improving programme specificity is important to minimise anxiety from false positive results. When considering cancer detection, AI test sensitivity alone is not sufficiently informative, and additional information on the spectrum of disease detected and interval cancers is crucial to better understand the benefits and harms of screening. Although large retrospective studies might provide useful evidence by directly comparing test accuracy and spectrum of disease detected between different AI systems and by population subgroup, most retrospective studies are biased due to differential verification (ie, the use of different reference standards to verify the target condition among study participants). Enriched, multiple-reader, multiple-case, test set laboratory studies are also biased due to the laboratory effect (ie, radiologists' performance in retrospective, laboratory, observer studies is substantially different to their performance in a clinical environment). Therefore, assessment of the effect of incorporating any AI system into the breast screening pathway in prospective studies is required as it will provide key evidence for the effect of the interaction of medical staff with AI, and the impact on women's outcomes. [Abstract copyright: Copyright © 2022 Elsevier Ltd. All rights reserved.]

Item Type: Journal Article
Subjects: R Medicine > R Medicine (General)
R Medicine > RA Public aspects of medicine
R Medicine > RC Internal medicine
Divisions: Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School
SWORD Depositor: Library Publications Router
Library of Congress Subject Headings (LCSH): UK National Screening Committee, Breast -- Cancer -- Diagnosis, Breast -- Cancer -- Diagnosis -- Data processing, Medical screening, Artificial intelligence -- Medical applications, Diagnostic imaging -- Data processing, Breast -- Radiography, Breast -- Radiography -- Data processing
Journal or Publication Title: The Lancet. Digital health
Publisher: Elsevier BV
ISSN: 2589-7500
Official Date: 1 July 2022
Dates:
DateEvent
1 July 2022Published
Volume: 4
Number: 7
Page Range: e558-e565
DOI: 10.1016/S2589-7500(22)00088-7
Status: Peer Reviewed
Publication Status: Published
Reuse Statement (publisher, data, author rights): ** From PubMed via Jisc Publications Router ** History: received 30-07-2021; revised 04-03-2022; accepted 06-04-2022.
Access rights to Published version: Restricted or Subscription Access
Date of first compliant deposit: 11 October 2022
Date of first compliant Open Access: 11 October 2022
RIOXX Funder/Project Grant:
Project/Grant IDRIOXX Funder NameFunder ID
CDF-2016-09-018National Institute for Health Researchhttp://dx.doi.org/10.13039/501100000272

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics

twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us